DK2739748T3 - Il22ra2-gen med fibrosefølsomhed og anvendelser deraf - Google Patents
Il22ra2-gen med fibrosefølsomhed og anvendelser deraf Download PDFInfo
- Publication number
- DK2739748T3 DK2739748T3 DK12741356.5T DK12741356T DK2739748T3 DK 2739748 T3 DK2739748 T3 DK 2739748T3 DK 12741356 T DK12741356 T DK 12741356T DK 2739748 T3 DK2739748 T3 DK 2739748T3
- Authority
- DK
- Denmark
- Prior art keywords
- il22ra2
- fibrose
- gen
- sensitivity
- il22ra2 gen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2539/00—Reactions characterised by analysis of gene expression or genome comparison
- C12Q2539/10—The purpose being sequence identification by analysis of gene expression or genome comparison characterised by
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161515438P | 2011-08-05 | 2011-08-05 | |
| EP11306018 | 2011-08-05 | ||
| PCT/EP2012/065222 WO2013020904A1 (en) | 2011-08-05 | 2012-08-03 | Fibrosis susceptibility il22ra2 gene and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2739748T3 true DK2739748T3 (da) | 2019-06-24 |
Family
ID=47667907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12741356.5T DK2739748T3 (da) | 2011-08-05 | 2012-08-03 | Il22ra2-gen med fibrosefølsomhed og anvendelser deraf |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10150989B2 (da) |
| EP (1) | EP2739748B1 (da) |
| JP (2) | JP6141275B2 (da) |
| KR (1) | KR102003835B1 (da) |
| CN (2) | CN107217092A (da) |
| BR (1) | BR112014002347B1 (da) |
| CA (1) | CA2843949C (da) |
| DK (1) | DK2739748T3 (da) |
| WO (1) | WO2013020904A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2221387A1 (en) | 2009-02-19 | 2010-08-25 | Université de la Méditerranée | Fibrosis susceptibility gene and uses thereof |
| EP3425056A1 (en) | 2017-07-07 | 2019-01-09 | Genepred Biotechnologies | Method for prognosing fibrosis progression |
| EP3864175A1 (en) | 2018-10-11 | 2021-08-18 | Genepred Biotechnologies | Method for detecting fibrosis especially keloid |
| JP7101358B1 (ja) * | 2021-06-21 | 2022-07-15 | クラシエホールディングス株式会社 | 肝臓疾患の発症リスクの検出方法、及び肝臓疾患の発症リスク検出用キット |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770209A (en) | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
| EP0730663B1 (en) | 1993-10-26 | 2003-09-24 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US20030092019A1 (en) | 2001-01-09 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia |
| CN1589403B (zh) | 2001-09-18 | 2011-06-01 | 法布罗根股份有限公司 | 测定结缔组织生长因子的方法 |
| WO2004085475A2 (en) * | 2003-03-24 | 2004-10-07 | Zymogenetics, Inc. | Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| GB0326780D0 (en) | 2003-11-18 | 2003-12-24 | Imp College Innovations Ltd | Biological materials and uses thereof |
| WO2006092650A2 (en) * | 2005-03-01 | 2006-09-08 | National Centre For Cell Sciences | A composition for creating an artificial bone -marrow like environment and use thereof |
| CN101500590A (zh) * | 2005-03-31 | 2009-08-05 | 阿根西斯公司 | 与161p2f10b蛋白结合的抗体和相关分子 |
| WO2007024715A2 (en) * | 2005-08-19 | 2007-03-01 | Abbott Laboratories | Dual variable domain immunoglobin and uses thereof |
| WO2007058776A2 (en) * | 2005-11-10 | 2007-05-24 | Receptor Biologix, Inc. | Hepatocyte growth factor intron fusion proteins |
| WO2007076422A2 (en) * | 2005-12-22 | 2007-07-05 | Dhy & Co., Ltd | Antibodies against interleukin-22 binding protein and its uses |
| EP2094289B1 (en) * | 2006-12-04 | 2013-03-13 | Promedior, Inc. | Combination of sap and enalapril for use in the treatment of fibrotic or fibroproliferative disorders |
| EP2221387A1 (en) | 2009-02-19 | 2010-08-25 | Université de la Méditerranée | Fibrosis susceptibility gene and uses thereof |
| EP2566978A1 (en) | 2010-05-04 | 2013-03-13 | Université d'Aix-Marseille | Antiviral treatment susceptibility gene and uses thereof |
-
2012
- 2012-08-03 CN CN201710224786.9A patent/CN107217092A/zh active Pending
- 2012-08-03 CN CN201280047401.1A patent/CN104302780B/zh active Active
- 2012-08-03 BR BR112014002347-6A patent/BR112014002347B1/pt active IP Right Grant
- 2012-08-03 EP EP12741356.5A patent/EP2739748B1/en active Active
- 2012-08-03 JP JP2014523339A patent/JP6141275B2/ja active Active
- 2012-08-03 CA CA2843949A patent/CA2843949C/en active Active
- 2012-08-03 DK DK12741356.5T patent/DK2739748T3/da active
- 2012-08-03 KR KR1020147006064A patent/KR102003835B1/ko active IP Right Grant
- 2012-08-03 WO PCT/EP2012/065222 patent/WO2013020904A1/en active Application Filing
- 2012-08-03 US US14/236,869 patent/US10150989B2/en active Active
-
2017
- 2017-05-02 JP JP2017091558A patent/JP2017176186A/ja active Pending
-
2018
- 2018-10-18 US US16/164,598 patent/US20190323060A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2739748B1 (en) | 2019-04-03 |
| JP6141275B2 (ja) | 2017-06-07 |
| JP2017176186A (ja) | 2017-10-05 |
| US20190323060A1 (en) | 2019-10-24 |
| JP2014524236A (ja) | 2014-09-22 |
| BR112014002347A2 (pt) | 2017-03-01 |
| WO2013020904A1 (en) | 2013-02-14 |
| CA2843949C (en) | 2021-01-12 |
| CA2843949A1 (en) | 2013-02-14 |
| KR102003835B1 (ko) | 2019-07-25 |
| US10150989B2 (en) | 2018-12-11 |
| CN107217092A (zh) | 2017-09-29 |
| CN104302780B (zh) | 2017-04-12 |
| EP2739748A1 (en) | 2014-06-11 |
| US20140295427A1 (en) | 2014-10-02 |
| KR20140058611A (ko) | 2014-05-14 |
| CN104302780A (zh) | 2015-01-21 |
| BR112014002347B1 (pt) | 2021-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021010I1 (el) | 4-ιμιδαζοπυριδαζιν-1-υλ-βενζαμιδια και 4-ιμιδαζοτριαζιν-1-υλ-βενζαμιδια ως αναστολεις βτκ | |
| DK2552261T3 (da) | Propfilter med proprum med aromakugle | |
| DK2914291T3 (da) | Anti-komplement-c1s-antistoffer og anvendelser deraf | |
| DK3415157T3 (da) | N-acyldipeptidderivater og anvendelser deraf | |
| BR112014027348A2 (pt) | compostos agonistas duplos gip-glp-1 e métodos | |
| DK2917790T3 (da) | Horologe med opbevaret og interchangeable face | |
| EP2715603A4 (en) | JOINT INVERSION WITH UNKNOWN LITHOLOGY | |
| DK3324622T3 (da) | Indikator med multiple regressioner og multiple farvekanaler | |
| BR112012017441A2 (pt) | compostos e métodos | |
| HK1206067A1 (en) | Versatile and sensitive biosensor | |
| DK2877576T3 (da) | Xyloseisomeraser og anvendelser deraf | |
| CO6990717A2 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| BR112014000049A2 (pt) | pirrolotriazinas substituídas com hidroximelilarilo e sua utilização | |
| FI20116089L (fi) | Järjestely ja laite | |
| FR2999415B1 (fr) | Sonde endo-ureterale amelioree | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| DK2921493T3 (da) | Heteroarylpiperidin og ¿piperazinderivater | |
| FI20126266A (fi) | Pehmopaperin mittaus | |
| DK3453723T3 (da) | Anti-ASIC1-antistoffer og anvendelser deraf | |
| DK2598525T3 (da) | Frataxin-mutanter | |
| DK3434614T3 (da) | Aftageligt dækningsapparat med flere dele og tilhørende | |
| DK2890819T4 (da) | Tane med udvidelsesorganer | |
| DK2679127T3 (da) | WC-komponenter og WC med aftageligt hængsel | |
| DK2871945T3 (da) | Organtransportapparat med prøvekamre | |
| DK2943460T3 (da) | 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf |